Protease-activated receptor 1 as a potential therapeutic target for COVID-19
Minireview
[키워드] acute respiratory distress
Anticoagulant
anticoagulation
caused
clinical symptom
Coagulation
Coagulopathy
coronavirus
COVID-19
diarrhea
disease
Dizziness
dry cough
Dyspnea
endothelial
Fever
headache
Immune-mediated
include
Inflammation
management
mechanism
Novel coronavirus
pathophysiology
Patient
physiological
poor prognosis
potential therapeutic target
prevalent
proinflammatory cytokines
Protease-activated receptor 1
Proteases
prothrombotic state
receptor
Regulation
Respiratory disease
SARS-CoV-2
severe COVID-19
Spread
supportive care
syndrome
the disease
thrombin
thrombin receptor
thrombosis
tissue damage
Treatment
Vaccine
vomiting
weakness
Wuhan, China
[DOI] 10.1177/1535370220978372 PMC 바로가기 [Article Type] Minireview
[DOI] 10.1177/1535370220978372 PMC 바로가기 [Article Type] Minireview